FectoVIR®-AAV
Available at research and GMP grade to intensify production of recombinant AAV rAAV viral vectors at any scale from benchtop to 2000L scale bioreactor...
Summary
Participants: Cassie-Marie Peigné, Scientific Support Specialist, Polyplus-transfection. Alan Dickson, Professor of Biotechnology at Centre of Excellence in Biopharmaceuticals, University of Manchester. Hélène Trottin, Senior Technical Specialist, Process Sciences at Pharmaron Gene Therapy.
This webinar will discuss some of the key upstream process parameters to consider for efficient and scalable AAV production with a focus on the transfection step.
Key messages:
- What are the critical upstream parameters for AAV production?
- What early process considerations are required to ensure success at large scale?
- What high-throughput technologies can accelerate development timelines and deliver a robust platform?
- How can innovation drive a fast-changing landscape?
Source: Pharmaron Gene therapy.
